πŸ‡ΊπŸ‡Έ FDA
Patent

US 9822157

Hepcidin analogues and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 9822157 (Hepcidin analogues and uses thereof) held by Protagonist Therapeutics, Inc. expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Protagonist Therapeutics, Inc.
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P3/00, A61P3/12